S. Han, et al.
Fitoterapia138(2019)104288
3.31), and expressed as δ values (ppm), with coupling constants (J)
reported in Hz. Column chromatography was performed on silica gel
(100–200 and 200–300 mesh, Qingdao Marine Chemical Factory,
Qingdao, People's Republic of China), Sephadex LH-20 gel (GE
Healthcare, Sweden), polyamide-gel (80–100 mesh, Taizhou Luqiao
Sijia Biochemical Plastic Factory, Zhejiang, China), MCI-gel CHP 20P
(75–150 μm, Tokyo, Japan) and ODS gel (60–80 μm, Merck, Germany).
TLC was carried out on precoated silica gel GF254 plates (Qingdao
Marine Chemical, Inc. China). Semipreparative reversed-phase HPLC
was performed on a Waters 1525 series pumping system equipped with
Brevisnoside B (7): yellow oil; [α]D20 − 39.0 (c 0.10, MeOH); 1H,
[M + Na]+ (calcd for C15H26O3, 277.1774).
Erigeroside 6′-palmitate (10): white, amorphous powder; 1H, 13C
[M + COOH]− (calcd for C27H44O9, 557.2965).
2.4. Sugar analysis
2.4.1. Acid hydrolysis
a
Waters 2489 UV detector using
a
YMC Pack ODS-A column
Acid hydrolysis was carried out to obtain the monosaccharide of
compound 10 [9]. Compound 10 (2.0 mg) was hydrolyzed with 1 M
aqueous HCl (4 mL) in a thermostatically controlled oil bath at 80 °C for
4 h. After cooling, the reaction mixture was extracted with EtOAc
(3 × 4 mL), and the H2O phase was then concentrated under vacuum
and dried to give a sugar residue. The residue was dissolved in H2O
(1.5 mL) and analyzed by a LCNetII/ADC HPLC with OR-4090 as the
detector and equipped with a Shodex Asahipak NH2P-50 4E column
using an isocratic solvent system of MeCN-H2O (3:1, v/v) at a flow rate
of 0.8 mL/min. The absolute configuration was determined by com-
paring the retention time and peak shape with standard sugar: D-glucose
(tR = 10.20 min) (Fig. S30). The sugar moiety of compound 10 was
identified to be D-glucose.
(250 × 10 mm, 5 μm). Chiral HPLC isolation was run on a Shimadzu
LC-10 CE liquid chromatography instrument equipped with a Shimadzu
SPD-M10A UV–vis detector by using Chiralpak AD-H column
(4.6 mm × 250 mm, 5 μm, Daicel Polymer Ltd., Tokyo, Japan).
2.2. Plant material
The whole plants of E. breviscapus were collected from Yunnan
Province, People's Republic of China, in May 2016. The plant materials
were identified by Professor Jincai Lu (Department of Pharmaceutical
Botany, School of Traditional Chinese Materia Medica, Shenyang
Pharmaceutical University, China). A voucher specimen (accession
number: DZXX-2016-1Y) was maintained at the specimen room of
Shenyang Pharmaceutical University.
2.4.2. Enzymatic hydrolysis
Compound 1 (1.0 mg) and snailase (2.0 mg) were dissolved in 3 mL
of potassium dihydrogen phosphate (KDP) buffer at pH 5.6 and 37 °C
for 5 h [10]. The reaction mixture was extracted with the same volume
of EtOAc three times. The EtOAc extracts and water-soluble layer were
evaporated to dryness in vacuum, respectively. The EtOAc extracts
were purified by semi-preparative HPLC (eluted with MeCN-H2O, 1:1,
v/v) to afford the aglycone of 1 (0.5 mg). Compound 2 (1.1 mg) was
hydrolyzed with the same procedure to afford monosaccharide.
LCNetII/ADC HPLC-OR analysis showed the presence of D-glucose of 1
and 2 (Fig. S30).
2.3. Extraction and isolation
The air-dried aerial parts of E. breviscapus (20 kg) were extracted
thrice with 80% EtOH at room temperature under reflux and evapo-
rated to dryness to obtain a crude extract (4 kg). This crude extract was
suspended in H2O and successively partitioned with CH2Cl2 to give
CH2Cl2-(600 g) and aqueous-soluble (3.2 kg) extracts upon evaporation
in vacuo. The H2O-soluble fraction was dissolved in MeOH and parti-
tioned by macroporous resin column chromatography (CC) eluted with
EtOH/H2O gradient (1:1, 7:3, and 8:2, v/v) to give three fractions Fr.1-
Fr.3. Fr.3 was fractionated by silica gel CC using CH2Cl2/MeOH/H2O
(9:1:0 to 1:1:0.8, v/v) to afford Fr.3.1-Fr.3.2 by TLC analysis. Fr.3.1 was
separated by polyamide column (MeOH/H2O, 6:4 to 8:2, v/v) followed
by Sephadex LH-20 with 60% MeOH/H2O to yield Fr.3.1.1-Fr.3.1.3.
Fr.3.1.2 was further divided into three portions (Fr.3.1.2.1-Fr.3.1.2.3)
by silica gel with CH2Cl2/MeOH, 50:1 to 1:1, v/v. Fr.3.1.2.1 and
Fr.3.1.2.2 were purified by ODS column (MeOH/H2O, 2:8 to 8:2, v/v)
and semipreparative HPLC to obtain 10 (6.0 mg) and 11 (20.0 mg),
respectively. Fr.3.1.2.3 was separated in a similar manner to Fr.3.1.2.1
to give mixed 1 and 2 (8 mg), 3 (3.5 mg), 4 (4.4 mg) and 5 (3.6 mg).
Subsequently, the separation of mixed 1 and 2 by chiral HPLC using a
Daicel Chiralpak AD-H chiral column eluted with n-hexane-isopropanol
(11:1, v/v) detection at 210 nm afforded 1 (2.0 mg) and 2 (2.1 mg).
The dried CH2Cl2 extract was subjected to polyamide CC eluted with
ethanol/H2O (1:9 to 9:1, v/v) followed by MCI gel CC using aqueous
ethanol to yield four fractions (Fr.1-Fr.4). Fr.1-Fr.4 were separated by
using silica gel CC eluted with (CH2Cl2/MeOH) and purified by semi-
preparative HPLC to give 6 (2.5 mg), 7 (2.2 mg), 8 (5.0 mg) and 9
(6.0 mg).
2.5. ECD calculations
The absolute configurations of the aglycone of 1 and 2 were de-
termined by using time-dependent density functional theory (TDDFT)
calculations. Conformational distribution of the optimized structures
was investigated at B3LYP/6-31G(d) and suggested the major con-
formers (> 98%). Energies of the geometric conformations in MeOH
were calculated at the B3LYP/6–311 + G(d) level. The hybrid B3LYP
functions were chose to run the TDDFT calculations, solving for 25
states for per molecule. The ECD of the conformers were performed by
the TDDFT method at the B3LYP/6-31G(d) level with the CPCM model
in methanol solution, and the overall ECD curves were produced by
2.6. Optical rotation calculations
A conformational search using the Molecular Merck force field
(MMFF) led to the identification of the major conformers (> 95%),
which was performed using the Gaussian 09 program at B3LYP/6-
31G(d) level [14]. Geometry optimization followed by OR calculations
at D-sodium line radiation (wavelength of 589 nm) in MeOH (CPCM)
using the B3LYP functional and the 6–311++G(2d,p) basis set for DFT.
Final calculated ORs were obtained as the result of the Boltzmann-
weighted average.
Brevisterpene A (1): colorless oil; ECD (MeOH) λmax (Δε) 204
(−3.30), 214 (−0.44), 245 (−0.46) nm; 1H, 13C NMR data (DMSO‑d6),
C20H34O7, 409.2191).
Brevisterpene B (2): colorless oil; ECD (MeOH) λmax (Δε) 202
(−2.99), 222 (+0.50), 243 (−0.61) nm; 1H, 13C NMR data (DMSO‑d6),
2.7. 13C NMR calculations
C
20H34O7, 409.2191).
Brevisnoside A (6): yellow oil; [α]D20 − 25.0 (c 0.10, MeOH); 1H,
After optimization of the major conformers (> 95%) was performed
using the Gaussian 09 program at B3LYP/6-31G(d) level. Computed
chemical shifts reported in this study were determined using the GIAO
[M + Na]+ (calcd for C15H26O2, 261.1825).
2